Sampling plans for use of rapid adenosine triphosphate (ATP) monitoring must overcome variability or suffer statistical invalidity

Greg S. Whiteley, Chris Derry, Trevor Glasbey

    Research output: Contribution to journalArticlepeer-review

    Abstract

    To the Editor—We write with respect to the article by Visrodia et al. on using a commercial rapid adenosine triphosphate (ATP) device for validation of cleaning of flexible gastroendoscopes. The importance of timeliness in quality assurance testing in this device area is critical owing to the time pressures on the use of the gastroendoscopes by clinical staff involved in patient care. The work is a useful additional contribution to this growing field of use for ATP devices.2 Nonetheless, we highlight concerns with 2 aspects of the method adopted within the work by Visrodia et al.
    Original languageEnglish
    Pages (from-to)236-237
    Number of pages2
    JournalInfection Control and Hospital Epidemiology
    Volume36
    Issue number2
    DOIs
    Publication statusPublished - 2015

    Fingerprint

    Dive into the research topics of 'Sampling plans for use of rapid adenosine triphosphate (ATP) monitoring must overcome variability or suffer statistical invalidity'. Together they form a unique fingerprint.

    Cite this